the pathophysiologic and molecular basis of … · 2019-04-18 · induced animal model of nafld...

1
THE PATHOPHYSIOLOGIC AND MOLECULAR BASIS OF NONALCOHOLIC STEATOHEPATITIS - ASSOCIATED CARDIOMYOPATHY (NAC) There is a paucity of data on the pathophysiological and molecular basis of myocardial dysfunction in non-alcoholic steatohepatitis (NASH). The Diet- induced animal model of NAFLD (DIAMOND) develops fatty liver, NASH and bridging fibrosis after 4, 16 and 36 weeks respectively, on a typical western diet (WD). 1 HYPOTHESIS : NASH-associated cardiomyopathy (NAC) is driven by pathways similar to those seen in NASH. DIAMOND mice have been shown to develop steatohepatitis (NASH) and associated liver fibrosis while on a WD SW diet. 1₁₁ As in the liver, these mice exhibit inflammatory and fibrotic changes in the myocardium, namely, non-alcoholic steatohepatitis- associated cardiomyopathy (NAC). The hallmark of these myocardial changes is Diastolic Dysfunction ( or Heart Failure with preserved ejection fraction, HFpEF). The similar pathophysiology b/n NAC and NASH provide potential therapeutic targeting for both entities. (1) To determine if the DIAMOND model reproduces the myocardial dysfunction seen in humans with NASH (2) To determine the histological, cell signaling and transcriptomic drivers of cardiac physiological changes. DIAMOND mice were fed chow diet (CD) or WD for 8 to 52 weeks (n=6-8/group). Trans-thoracic echocardiography was performed. H&E, Sirius Red stains and electron microscopy (EM) were performed. Molecular analysis (PCR/Western blot) of pathways related to NASH pathogenesis, and unbiased analysis (RNA Seq) to evaluate the transcriptome were performed. REFERENCES Contact information [email protected] Abdul Oseini 1 , Stefano Toldo 5 , Mulugeta Seneshaw 1 , Divya P. Kumar 1 , Prasanna K. Santhekadur 1 , Hae-Ki Min 1 , Eleonora Mezzaroma 5 , Pierre Bedossa 2 , A. Gabriele Mauro 5 , Federico Quaini 3 , Caterina Frati 3 , Angela Falco 3 , Srinivas Koduru 4 , Bubu A. Banini 1 , Faridoddin Mirshahi 1 , Antonio Abbate 5 , Oliver Rider 6 , Mohammad Siddiqui 1 , Arun J. Sanyal 1 BACKGROUND RESULTS AIMS CONCLUSION Figure abbreviations : CD NW , chow diet, normal water; WD SW , Western diet, sugar water; NAFL , non-alcoholic fatty liver; NASH, non alcoholic steatohepatitis; BF , bridging fibrosis. NB: * p value <0.05; ** p value < 0.001. 1. Asgharpour et al.; J Hep 2016 1. Div. of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, United States. 2. Hospital Beaujon, Clichy, France. 3. University of Parma, Parma, Italy. 4. Gene Arrays, Entity of Vedic Research, Inc, New York, NY, United States. 5. Division of Cardiology, Virginia Commonwealth University, Richmond, VA, United States. 6. Division of Cardiology, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.

Upload: others

Post on 03-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: THE PATHOPHYSIOLOGIC AND MOLECULAR BASIS OF … · 2019-04-18 · induced animal model of NAFLD (DIAMOND) develops fatty liver, NASH and bridging fibrosis after 4, 16 and 36 weeks

THE PATHOPHYSIOLOGIC AND MOLECULAR BASIS OF NONALCOHOLIC STEATOHEPATITIS-ASSOCIATED CARDIOMYOPATHY (NAC)

There is a paucity of data on the pathophysiologicaland molecular basis of myocardial dysfunction innon-alcoholic steatohepatitis (NASH). The Diet-induced animal model of NAFLD (DIAMOND)develops fatty liver, NASH and bridging fibrosisafter 4, 16 and 36 weeks respectively, on a typicalwestern diet (WD).1

HYPOTHESIS: NASH-associated cardiomyopathy(NAC) is driven by pathways similar to those seen inNASH.

• DIAMOND mice have been shown to developsteatohepatitis (NASH) and associated liverfibrosis while on a WD SW diet.1₁₁

• As in the liver, these mice exhibit inflammatoryand fibrotic changes in the myocardium,namely, non-alcoholic steatohepatitis-associated cardiomyopathy (NAC).

• The hallmark of these myocardial changes isDiastolic Dysfunction ( or Heart Failure withpreserved ejection fraction, HFpEF).

• The similar pathophysiology b/n NAC andNASH provide potential therapeutic targetingfor both entities.

(1) To determine if the DIAMOND modelreproduces the myocardial dysfunction seen inhumans with NASH

(2) To determine the histological, cell signaling andtranscriptomic drivers of cardiac physiologicalchanges.

DIAMOND mice were fed chow diet (CD) or WD for8 to 52 weeks (n=6-8/group). Trans-thoracicechocardiography was performed. H&E, Sirius Redstains and electron microscopy (EM) wereperformed. Molecular analysis (PCR/Western blot)of pathways related to NASH pathogenesis, andunbiased analysis (RNA Seq) to evaluate thetranscriptome were performed.

REFERENCES

Contact [email protected]

Abdul Oseini1, Stefano Toldo5, Mulugeta Seneshaw1, Divya P. Kumar1, Prasanna K. Santhekadur1, Hae-Ki Min1, Eleonora Mezzaroma5, Pierre Bedossa2, A.

Gabriele Mauro5, Federico Quaini3, Caterina Frati3, Angela Falco3, Srinivas Koduru4, Bubu A. Banini1,

Faridoddin Mirshahi1, Antonio Abbate5, Oliver Rider6, Mohammad Siddiqui1, Arun J. Sanyal1

BACKGROUND RESULTS

AIMS

CONCLUSION

Figure abbreviations: CD NW, chow diet, normal water; WD SW, Western diet, sugar water; NAFL, non-alcoholic fatty liver; NASH, non alcoholic steatohepatitis; BF, bridging fibrosis. NB: * p value <0.05; ** p value < 0.001.

1. Asgharpour et al.; J Hep 2016

1. Div. of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, United States. 2. Hospital Beaujon, Clichy, France. 3. University of

Parma, Parma, Italy. 4. Gene Arrays, Entity of Vedic Research, Inc, New York, NY, United States. 5. Division of Cardiology, Virginia Commonwealth University, Richmond,

VA, United States. 6. Division of Cardiology, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.